Skip to main content
Clinical Trials/CTRI/2021/12/038350
CTRI/2021/12/038350
Not yet recruiting
Phase 2

A wearable system for quantitative assessment and recovery prediction during gait restoration in Parkinsonâ??s and Cerebellar Ataxia Patients

DST0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: R270- Ataxia, unspecifiedHealth Condition 2: G20- Parkinsons disease
Sponsor
DST
Status
Not yet recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
DST

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of PD, based on UK brain bank criteria for diagnosis of PD.
  • Hoehn and Yahr stage from 1 to3\.
  • On stable dopaminergic drugs for at least 30 days
  • Genetically confirmed SCA\-2 and SCA\-12\.
  • Subjects 30 and above on stable medication for at least 30 days.

Exclusion Criteria

  • Features suggestive of other causes of Parkinsonism or Parkinson plus syndrome.
  • Subjects with neuropsychiatric co\-morbidity
  • Subjects with hypertension or diabetes would be excluded if uncontrolled on drugs.
  • Subjects with pregnancy.
  • Subjects with any orthopedic illness (arthitis etc.)

Outcomes

Primary Outcomes

Not specified

Similar Trials